AIM ImmunoTech
AIM
#11024
Rank
A$9.04 M
Marketcap
A$0.23
Share price
1.29%
Change (1 day)
-90.61%
Change (1 year)

Earnings for AIM ImmunoTech (AIM)

Earnings in 2026 (TTM): -A$19.82 Million

According to AIM ImmunoTech 's latest financial reports the company's current earnings are A$0.09 Million. In 2025 the company made an earning of -A$20.17 Million, an increase over its 2024 earnings that were of -A$25.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AIM ImmunoTech from 1995 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$19.82 Million-1.71%
2025 -A$20.17 Million-19.41%
2024 -A$25.02 Million-40.2%
2023 -A$41.84 Million48.94%
2022 -A$28.09 Million1.66%
2021 -A$27.63 Million32.66%
2020 -A$20.83 Million51.18%
2019 -A$13.78 Million-2.81%
2018 -A$14.18 Million18.82%
2017 -A$11.93 Million10.09%
2016 -A$10.84 Million-50.74%
2015 -A$22 Million-12.72%
2014 -A$25.21 Million7.55%
2013 -A$23.44 Million-6.51%
2012 -A$25.07 Million21.22%
2011 -A$20.68 Million-7.56%
2010 -A$22.37 Million16.76%
2009 -A$19.16 Million3.54%
2008 -A$18.51 Million-33.58%
2007 -A$27.87 Million3.18%
2006 -A$27.01 Million89.3%
2005 -A$14.27 Million-9.31%
2004 -A$15.73 Million50.17%
2003 -A$10.48 Million9.55%
2002 -A$9.57 Million-24.79%
2001 -A$12.72 Million-2.66%
2000 -A$13.07 Million-6.78%
1999 -A$14.02 Million40.58%
1998 -A$9.97 Million6.15%
1997 -A$9.39 Million41.3%
1996 -A$6.65 Million360%
1995 -A$1.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.12 Billion 501.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.23 Million 36.76%๐Ÿ‡บ๐Ÿ‡ธ USA